Acute and chronic administration of intranasal oxytocin and vasopressin have been
extensively utilized in both animal models and human preclinical and clinical studies over …

The high prevalence of metabolic syndrome in persons with schizophrenia has spurred
investigational efforts to study the mechanism beneath its pathophysiology. Early psychosis …

Background Intranasal administration of oxytocin is increasingly explored as a new
approach to facilitate social development and reduce disability associated with a diagnosis …

Introduction: There are currently no approved drug interventions for social behavior
dysfunction in autism spectrum disorder (ASD). Previous trials investigating effects of daily …

Background Postpartum hemorrhage remains a key contributor to overall maternal morbidity
in the United States. Current clinical assessment methods used to predict postpartum …

Intranasal oxytocin exerts wide-ranging effects on socioemotional behavior and is proposed
as a potential therapeutic intervention in psychiatric disorders. However, following intranasal …

Intranasal oxytocin (OT) has been suggested as a putative adjunctive treatment for patients
with schizophrenia and autism spectrum disorders (ASD). Here, we examine available …

Introduction: Anxiety disorders are prevalent mental conditions characterized by
exaggerated anxious arousal and threat reactivity. Animal and human studies suggest an …

The respective roles of the neuropeptides arginine vasopressin (AVP) and oxytocin (OXT) in
modulating social cognition and for therapeutic intervention in autism spectrum disorder …

Possible interactions of the neuropeptide oxytocin and the sex hormone estradiol may
contribute to previously observed sex-specific effects of oxytocin on resting-state functional …